ProCE Banner Activity

Optimizing Antimicrobial Management and Tackling Resistance in Gram-Negative HAP/VAP Infections

Slideset

In this downloadable slideset, learn about the role of novel agents in the management of HAP/VAP, approaches to identify patients at risk for multidrug–resistant organisms based on local resistance patterns and patient-specific factors, along with strategies, such as rapid diagnostic testing, advanced antibiograms, and clinical prediction scores, to help reduce time to effective therapy.

Released: May 09, 2023

Share

Provided by

Provided by ProCE, LLC and Clinical Care Options, LLC, in partnership with the Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from Merck Sharp & Dohme, LLC.

Merck Sharp & Dohme, LLC

Partners

Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner